Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 34 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Operating Activities:          
Net loss     $ (6,242) $ (9,528)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization [note 3]     126 130  
Stock-based compensation [note 6 [c] and note 6 [d]] $ 308 $ 317 610 607  
Changes in operating assets and liabilities:          
Amounts receivable     8    
Prepaid expenses and other assets     (142) 510  
Accounts payable     (336) 563  
Accrued liabilities other     10 (402)  
Accrued clinical liabilities     (314) (307)  
Accrued compensation     (381) (313)  
Lease obligation [note 7]     2 10  
Net cash used in operating activities     (6,659) (8,730)  
Financing Activities:          
Proceeds from exercise of warrants, net of issuance costs     589 4,199  
Net cash provided by financing activities     2,120 4,622  
Investing Activities:          
Purchase of property and equipment     (14) (52)  
Purchase of investments       (25)  
Proceeds from maturities of investments       5,114  
Net cash provided by (used in) investing activities     (14) 5,037  
Effect of exchange rate changes on cash       2  
Net increase (decrease) in cash, cash equivalents and restricted cash     (4,553) 931  
Cash, cash equivalents and restricted cash at beginning of the period     16,714 9,565  
Cash, cash equivalents and restricted cash at end of the period $ 12,161 $ 10,496 12,161 10,496 $ 12,161
LPC [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement         $ (500)
LPC [Member] | Purchase Agreement [Member]          
Financing Activities:          
Proceeds financing and purchase agreement, net of issuance costs       $ 423  
Financing costs relating to public offering and purchase agreement     (14)    
December 2019 Public Offering [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement     (34)    
April 2020 Financing [Member]          
Financing Activities:          
Proceeds financing and purchase agreement, net of issuance costs     $ 1,579